Glycan-based DC-SIGN targeting to enhance antigen cross-presentation in anticancer vaccines

OncoImmunology

Volumn 2, Issue 2, 2013, Pages

  García Vallejo, Juan J ^a   Unger, Wendy W J ^a   Kalay, Hakan ^a   van Kooyk, Yvette ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell surface molecules; DC SIGN; Dendritic cells; Glycans; Human; Rodent

Indexed keywords

CANCER VACCINE; CD209 ANTIGEN; DENDRITIC CELL VACCINE; GLYCAN; PATTERN RECOGNITION RECEPTOR; TOLL LIKE RECEPTOR 4;

BINDING AFFINITY; CANCER IMMUNOLOGY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL ASSAY; CELL MATURATION; CELLULAR IMMUNITY; CROSS PRESENTATION; DENDRITIC CELL; HUMAN; LYMPHOCYTE PROLIFERATION; MOLECULAR RECOGNITION; NONHUMAN; NOTE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; VACCINE PRODUCTION;

EID: 84886064283     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/onci.23040     Document Type: Note

References (10)

1. Steinman RM. Decisions about dendritic cells: past, present, and future. Annu Rev Immunol 2012; 30:1-22; PMID:22136168; http://dx.doi.org/10.1146/annurev-immunol-100311-102839.
2. Caminschi I, Maraskovsky E, Heath WR. Targeting Dendritic Cells in vivo for Cancer Therapy. Front Immunol 2012; 3:13; PMID:22566899; http://dx.doi. org/10.3389/fimmu.2012.00013.
3. Geijtenbeek TB, Torensma R, van Vliet SJ, van Duijnhoven GCF, Adema GJ, van Kooyk Y, et al. Identification of DC-SIGN, a novel dendritic cell-specific ICAM-3 receptor that supports primary immune responses. Cell 2000; 100:575-85; PMID:10721994; http://dx.doi.org/10.1016/S0092-8674(00)80693-5.
4. Appelmelk BJ, van Die I, van Vliet SJ, Vandenbroucke-Grauls CM, Geijtenbeek TB, van Kooyk Y. Cutting edge: carbohydrate profiling identifies new pathogens that interact with dendritic cell-specific ICAM-3-grabbing nonintegrin on dendritic cells. J Immunol 2003; 170:1635-9; PMID:12574325.
5. Mitchell DA, Fadden AJ, Drickamer K. A novel mechanism of carbohydrate recognition by the C-type lectins DC-SIGN and DC-SIGNR. Subunit organization and binding to multivalent ligands. J Biol Chem 2001; 276:28939-45; PMID:11384997; http://dx.doi. org/10.1074/jbc.M104565200.
6. Cambi A, Lidke DS. Nanoscale membrane organization: where biochemistry meets advanced microscopy. ACS Chem Biol 2012; 7:139-49; PMID:22004174; http://dx.doi.org/10.1021/cb200326g.
7. García-Vallejo JJ, Ambrosini M, Overbeek A, van Riel WE, Bloem KE, Unger WW, et al. Multivalent glycopeptide dendrimers for the targeted delivery of antigens to dendritic cells. Mol Immunol 2013; 53:387-97; PMID:23103377; http://dx.doi.org/10.1016/j. molimm.2012.09.012.
8. Biricova V, Laznickova A. Dendrimers: Analytical characterization and applications. Bioorg Chem 2009; 37:185-92; PMID:19703699; http://dx.doi. org/10.1016/j.bioorg.2009.07.006.
9. Unger WWJ, van Beelen AJ, Bruijns SC, Joshi M, Fehres CM, van Bloois L, et al. Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells. J Control Release 2012; 160:88-95; PMID:22366522; http://dx.doi.org/10.1016/j.jconrel.2012.02.007.
10. Engering A, Geijtenbeek TB, van Vliet SJ, Wijers M, van Liempt E, Demaurex N, et al. The dendritic cell-specific adhesion receptor DC-SIGN internalizes antigen for presentation to T cells. J Immunol 2002; 168:2118-26; PMID:11859097.